Biochemical Assessment of Insulin and Dopamine 2 Receptors in Patients with Type 2 Diabetes

Khitam Abed Sahil; Nazar Shiyaa Mohammed; Yousr Majd Jmeel; Anil K Sharma

doi:10.51173/jt.v5i4.1683

Authors

Khitam Abed Sahil Medical Laboratory science technologist, Baghdad Health Department, Al Russiaf, Al Nahrawan Sector, Baghdad, Iraq
Nazar Shiyaa Mohammed College of Health & Medical Technology - Baghdad, Middle Technical University, Baghdad, Iraq
Yousr Majd Jmeel Institute of Medical Technology / Mansour, Middle Technical University, Baghdad, Iraq
Anil K Sharma Maharishi Markandeshwar University, Mullana-Ambala (Haryana), India

DOI:

https://doi.org/10.51173/jt.v5i4.1683

Keywords:

Head and Neck, Cancer, Intraoral Stent, Radiotherapy, Oral Mucositis

Abstract

Dopamine (DA) plays a key role in the body's regulation of insulin production. This study aimed to estimate insulin and dopamine 2 receptors in type 2 diabetic patients. The study included 180 subjects aged (20-65) years during the period from November 2022 to March 2023. They were divided into two groups: 120 patients with type 2 Diabetes mellitus (60 males and 60 females), and 60 healthy individuals (30 males and 30 females) as a control group. The biochemical tests (insulin and dopamine 2) were measured by the Human Insulin ELISA kit and Human Dopamine 2 receptor ELISA kit in Bioassay Technology Laboratory. The HbA1c, urea, and creatinine were measured by the kit from Roche/ Hetachi Diagnostics Ltd Company. The fasting blood glucose and HbA1c were measured to diagnose all patients with T2DM and controls to confirm the subjects with T2DM. The samples were obtained from the AL Kinday Hospital and Endocrine Center in Baghdad, Iraq.

The results of this study explained that the patients and controls were comparable in age, gender, and smoking status with no significant differences (P> 0.05). while results reported that there was a greater significant difference (p<0.01) in levels of the mean for fasting blood sugar (FBS), glycated hemoglobin (HbA1c), and a significant difference (p<0.05) in urea and creatinine levels between the type 2 diabetic patients and the controls there was a significant difference detected in values of insulin and dopamine 2(p<0/05) between the patient and control groups.

It can be concluded from our study that those who had type 2 diabetes mellitus had higher levels of dopamine and insulin when compared with the control group.

Downloads

Download data is not yet available.

Author Biographies

Khitam Abed Sahil, Medical Laboratory science technologist, Baghdad Health Department, Al Russiaf, Al Nahrawan Sector, Baghdad, Iraq

Nazar Shiyaa Mohammed, College of Health & Medical Technology - Baghdad, Middle Technical University, Baghdad, Iraq

Yousr Majd Jmeel, Institute of Medical Technology / Mansour, Middle Technical University, Baghdad, Iraq

Anil K Sharma, Maharishi Markandeshwar University, Mullana-Ambala (Haryana), India

Department of Bio- Sciences and Technology

References

Y. Mukhtar, A. Galalain, U. Yunusa, “A modern overview on diabetes mellitus: A chronic endocrine disorder”, European Journal of Biology, vol. 5, No. 2, pp. 1–14,2020. doi:10.47672/ejb.409.

R. Balaji, Duraisamy, M. Kumar, “Complications of diabetes mellitus: A review.,” Drug Invention Today, Vol. 12, No. 2, 2019, doi.org/10.1002/hsr2.1096.

J. Ozougwu, K. Obimba, C. Belonwu, C. Unakalamba, “The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol., vol. 4, No. 4, pp. 46-57, 2019, doi: 10.22038/IJBMS.2019.13989.

S. Pinney, R. Simmons. “Metabolic programming, epigenetics, and gestational diabetes mellitus”, Current diabetes reports, vol. 12, No. 1, pp. 67-74, 2012.doi: 10.3390/nu12020376.

C.G., Awuchi, C. K, V.S.Echeta Igwe. “Diabetes and the nutrition and diets for its prevention and treatment: a systematic review and dietetic perspective”, Health Sciences Research, vol. 6, No. 1, pp. 5-19. 2020, doi: 10.1007/s13300-018-0500-7.

C. Bucolo, G Leggio, F. Drago, S. Salomone, “Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas”, Pharmacology & Therapeutics, vol. 20, No. 3, pp. 107392, 2019, doi: 10.3390/biom11030418.

G. Tavares, D. Rosendo-Silva, F. Simões, H. Eickhoff, “Circulating Dopamine Is Regulated by Dietary Glucose and Controls Glucagon-like 1 Peptide Action in White Adipose Tissue.,” International Journal of Molecular Sciences, vol. 24, No. 3, pp. 2464, 2023. doi:10.3390/ijms24032464.

Y. Chien, S. Chen, W. Li, “Dopamine receptor agonists mechanism of actions on glucose lowering and their connections with prolactin actions.,” Frontiers in Clinical Diabetes and Healthcare, vol. 4, 2023.doi: 10.3389/fcdhc.2023.935872.

A. Helman, A. Klochendler, N. Azazmeh, Y. Gabai, E. Horwitz, S. Anzi, “p16Ink4a-induced senescence of pancreatic beta cells enhances insulin secretion.,” Nature medicine.vol. 22, No. 4, pp. 412-20, 2016. doi: 10.1038/nm.4054.

R. Perry, R. Shankar, N. Fineberg, J. McGill, A. Baron, “HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).,” Diabetes Care, vol. 24, No. 3, pp. 465-71, 2001. doi: 10.1186/1472-6823-13-44.

D. Campagna, A. Alamo, A. Di Pino, C. Russo, A. Calogero, F. Purrello, “Smoking and diabetes: dangerous liaisons and confusing relationships.,” Diabetology & metabolic syndrome, vol. 11, No. 1, pp. 1-12, 2019. doi:10.1007/s11277-020-07552-3

Y. Wang, Z. Shan, M. Arvizu, A. Pan, J. Manson, S. Missmer, “Associations of menstrual cycle characteristics across the reproductive life span and lifestyle factors with risk of type 2 diabetes.,” JAMA network open, vol. 3, No. 12, pp. e2027928-e, 2020. doi: 10.1001/jamanetworkopen.2020.27928.

G. Gallucci, A. Tartarone, R. Lerose, A. Lalinga, A. Capobianco, “Cardiovascular risk of smoking and benefits of smoking cessation.,” Journal of thoracic disease, vol. 12, No. 7, pp. 3866, 2012. doi: 10.21037/jtd.2020.02.47.

C. Huang, G. Chen, M. Zhang, Y. Lu, Y. Hua, Y. Hu, “Association between environmental tobacco smoke exposure and risk of type 2 diabetes mellitus in Chinese female never smokers: A population‐based cohort study.,” Journal of Diabetes, vol. 12, No. 4, pp. 339-46, 2020, https://doi.org/10.1111/1753-0407.13001.

M. Salem, M. Ismail, A. Ghorab, R. Fouad, O. Mosbah, G. Khalifa, “Study of Lipoprotein-Associated Phospholipase A2 as a Potential Biomarker for Diabetic Kidney Disease in Type 2 Diabetes.,” The Egyptian Journal of Hospital Medicine, vol. 88, No. 1, pp. 4062-7, 2022. doi: 10.21608/EJHM.2022.254086.

C. Diniz, Z. McKenna, L. Canuto, F. Magalhães, C. Machado-Moreira, E. Shibuya, “A preliminary evaluation of the kidney function of sugarcane cutters from Brazil,” Journal of Occupational and Environmental Medicine, vol. 63, No. 2, pp. e53-e8, 2021.doi:10.1177/10998004211016070.

S. Kawahito, ‘Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress,” World journal of gastroenterology: WJG, Vol. 15, No. 33, pp. 4137, 2009, doi: 10.3748/wjg.15.4137.

J. Korner, ‘A role for foregut tyrosine metabolism in glucose tolerance, ” Molecular Metabolism, Vol. 23, pp. 37–50, 2009. doi: 10.1016/j.molmet.2019.02.008.

I. Dekkers, ‘Obesity and the brain: structural and functional imaging studies, and opportunities for large-scale imaging genetics’, in Visceral and Ectopic Fat. Elsevier, vol. 53, no. 61, pp. 11420, 2023. doi: 10.3390/ijms23179807.

Dekkers, J. Jiang, H. Lamb, P. Jansen, “Obesity and the brain: structural and functional imaging studies, and opportunities for large-scale imaging genetics,” Visceral and Ectopic Fat: Elsevier, vol. 15, No. 4. pp. 281-93, 2023, doi: 10.1016/S2213-8587(19)30084-1.

P. Kolodziejski, N. Leciejewska, A. Chmurzynska, M. Sassek, A. Szczepankiewicz, D. Szczepankiewicz , “30-Day spexin treatment of mice with diet-induced obesity (DIO) and type 2 diabetes (T2DM) increases insulin sensitivity, improves liver functions and metabolic status,” Molecular and Cellular Endocrinology, vol. 53, no. 61, pp. 11420, 2021. doi: 10.3390/ijms23179807.

H. Wang, L. Peng, Y. Chai, R. Yuan, “High-sensitive electrochemiluminescence C-peptide biosensor via the double quenching of dopamine to the novel Ru (II)-organic complex with dual intramolecular self-catalysis,” Analytical chemistry, vol. 89, No. 20, pp. 11076-82, 2017.doi: 10.1021/acs.analchem.7b03125.

G. Reynolds, S. Kirk. “Metabolic side effects of antipsychotic drug treatment–pharmacological mechanisms,” Pharmacology & therapeutics, vol. 25, no. 1, pp. 169-79, 2009. doi: 10.1016/j.pharmthera.2009.10.010.

Chen, X. et al. Prevalence of abdominal obesity in Chinese middle-aged and older adults with a normal body mass index and its association with type 2 diabetes mellitus: a nationally representative cohort study from 2011 to 2018‟, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, pp. 4829–4841202,2020. doi: 10.2147/DMSO.S339066.

Chen, Z., Hu, H., Chen, M., Luo, X., Yao, W., Liang, Q., ... & Wang, X.,"Association of Triglyceride to high-density lipoprotein cholesterol ratio and incident of diabetes mellitus: a secondary retrospective analysis based on a Chinese cohort study." Lipids in health and disease 19 (1), 1-11, 2020, https://doi.org/10.1186/s12944-020-01213-x.

Chien, H.-Y., Chen, S.-M. and Li, W.-C. “Dopamine receptor agonists mechanism of actions on glucose lowering and their connections with prolactin actions‟, Frontiers in Clinical Diabetes and Healthcare, 4, pp. 935872, 2023, doi: 10.3389/fcdhc.2023.935872.

D‟Elia, J. A. et al. „Variations in glucose/C-peptide ratio in patients with type 2 diabetes associated with renal function‟, Diabetes Research and Clinical Practice, 150, pp. 1–7, 2019, DOI: 10.1016/j.diabres.2019.02.015.

Dekkers, I. A. et al. “Obesity and the brain: structural and functional imaging studies, and opportunities for large-scale imaging genetics‟, in Visceral and Ectopic Fat. Elsevier, pp. 281–293,2023. doi.org/10.1016/B978-0-12-822186-0.00023-7.

Diniz, C. O., McKenna, Z., Canuto, L., Magalhães, F., Machado-Moreira, C. A., Shibuya, E., ... & Amorim, F. T., “A preliminary evaluation of the kidney function of sugarcane cutters from Brazil”, Journal of Occupational and Environmental Medicine, 63(2), e53-e58, 2021, DOI: 10.1097/JOM.0000000000002090.

Drożdż, D., Drożdż, M. and Wójcik, M. “Endothelial dysfunction as a factor leading to arterial hypertension‟, Pediatric Nephrology, pp. 1–13, 2022, https://doi.org/10.1007/s00467-022-05802-z.

Z. Farino, et al. (2020) „New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion‟, Molecular psychiatry, 25(9), pp. 2070–2085. DOI: 10.1038/s41380-018-0344-6.

Feldman, D. A. and Ryndina, N. G. “Interaction of asymmetric dimethylarginine, troponin I level, and diabetes mellitus 2 type severity in patients with acute myocardial infarction‟, Asian Journal of Health Sciences, 8(2), pp. ID44–ID44,2022. DOI: https://doi.org/10.15419/ajhs.v8i2.515.

Foteinopoulou, E. et al. “Impact of routine clinic measurement of serum C‐peptide in people with a clinician‐diagnosis of type diabetes‟, Diabetic Medicine, 38(7), p. e14449,2021. DOI: 10.1111/dme.14449.

Gallucci, G. et al. “Cardiovascular risk of smoking and benefits of smoking cessation‟, Journal of thoracic disease, 12(7), p. 3866,2020, https://doi.org/10.21037%2Fjtd.2020.02.47.